A media release from the Uniformed Services University of the Health Sciences last week announced the development of a highly specific assay for the detection of ERG oncoprotein. The assay is based on the development of an anti-ERG monoclonal antibody that appears to be capable of detecting the presence of ERG oncoprotein with > 99 percent accuracy. … READ MORE …
Filed under: Uncategorized | Tagged: ERG, monoclonal antibody, oncoprotein, test | Leave a comment »
TRACON Pharmaceuticals has announced the initiation of a Phase I/II clinical trial of its investigational monoclonal antibody TRC 105 for the treatment of patients with metastatic, castration-resistant prostate cancer (CRPC). … READ MORE …
Filed under: Drugs in development | Tagged: monoclonal antibody, TRC 105 | Leave a comment »
“Found, the super molecule to kill prostate cancer cells,” trumpeted the MailOnline. And worse still, “A miracle molecule has been discovered that offers the hope of saving men with currently incurable prostate cancer,” screamed the Press Association. … READ MORE …
Filed under: Drugs in development | Tagged: F77, hype, MAb, media, monoclonal antibody | 15 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 